<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Hong R</submitter><funding>shandong provincial natural science foundation</funding><funding>MOST | National Natural Science Foundation of China (NSFC)</funding><funding>MOST | National Natural Science Foundation of China</funding><pagination>1055-1074</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC10933415</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>25(3)</volume><pubmed_abstract>Activation of hepatic stellate cells (HSCs) plays a critical role in liver fibrosis. However, the molecular basis for HSC activation remains poorly understood. Herein, we demonstrate that primary cilia are present on quiescent HSCs but exhibit a significant loss upon HSC activation which correlates with decreased levels of the ciliary protein intraflagellar transport 88 (IFT88). Ift88-knockout mice are more susceptible to chronic carbon tetrachloride-induced liver fibrosis. Mechanistic studies show that the X-linked inhibitor of apoptosis (XIAP) functions as an E3 ubiquitin ligase for IFT88. Transforming growth factor-β (TGF-β), a profibrotic factor, enhances XIAP-mediated ubiquitination of IFT88, promoting its proteasomal degradation. Blocking XIAP-mediated IFT88 degradation ablates TGF-β-induced HSC activation and liver fibrosis. These findings reveal a previously unrecognized role for ciliary homeostasis in regulating HSC activation and identify the XIAP-IFT88 axis as a potential therapeutic target for liver fibrosis.</pubmed_abstract><journal>EMBO reports</journal><pubmed_title>XIAP-mediated degradation of IFT88 disrupts HSC cilia to stimulate HSC activation and liver fibrosis.</pubmed_title><pmcid>PMC10933415</pmcid><funding_grant_id>32000524</funding_grant_id><funding_grant_id>31991193</funding_grant_id><funding_grant_id>32100948</funding_grant_id><funding_grant_id>ZR2020QC076</funding_grant_id><pubmed_authors>Yang J</pubmed_authors><pubmed_authors>Li D</pubmed_authors><pubmed_authors>Liu M</pubmed_authors><pubmed_authors>Ni H</pubmed_authors><pubmed_authors>Yu F</pubmed_authors><pubmed_authors>Sun T</pubmed_authors><pubmed_authors>Zhong W</pubmed_authors><pubmed_authors>Wang J</pubmed_authors><pubmed_authors>Yang Y</pubmed_authors><pubmed_authors>Huang Z</pubmed_authors><pubmed_authors>Bu W</pubmed_authors><pubmed_authors>Li T</pubmed_authors><pubmed_authors>Tian X</pubmed_authors><pubmed_authors>Tan Y</pubmed_authors><pubmed_authors>Wang X</pubmed_authors><pubmed_authors>Yang S</pubmed_authors><pubmed_authors>Hong R</pubmed_authors><pubmed_authors>Zhou J</pubmed_authors></additional><is_claimable>false</is_claimable><name>XIAP-mediated degradation of IFT88 disrupts HSC cilia to stimulate HSC activation and liver fibrosis.</name><description>Activation of hepatic stellate cells (HSCs) plays a critical role in liver fibrosis. However, the molecular basis for HSC activation remains poorly understood. Herein, we demonstrate that primary cilia are present on quiescent HSCs but exhibit a significant loss upon HSC activation which correlates with decreased levels of the ciliary protein intraflagellar transport 88 (IFT88). Ift88-knockout mice are more susceptible to chronic carbon tetrachloride-induced liver fibrosis. Mechanistic studies show that the X-linked inhibitor of apoptosis (XIAP) functions as an E3 ubiquitin ligase for IFT88. Transforming growth factor-β (TGF-β), a profibrotic factor, enhances XIAP-mediated ubiquitination of IFT88, promoting its proteasomal degradation. Blocking XIAP-mediated IFT88 degradation ablates TGF-β-induced HSC activation and liver fibrosis. These findings reveal a previously unrecognized role for ciliary homeostasis in regulating HSC activation and identify the XIAP-IFT88 axis as a potential therapeutic target for liver fibrosis.</description><dates><release>2024-01-01T00:00:00Z</release><publication>2024 Mar</publication><modification>2025-04-26T14:17:13.103Z</modification><creation>2025-04-06T14:33:54.438Z</creation></dates><accession>S-EPMC10933415</accession><cross_references><pubmed>38351372</pubmed><doi>10.1038/s44319-024-00092-y</doi></cross_references></HashMap>